TGFB1 and neoplasm: In addition, epigenetics may also modulate the function of immunosuppressive cells in the tumor microenvironment, including regulatory T cells and myeloid-derived suppressor cells, which cause resistance to immunotherapy through the secretion of inhibitory cytokines, including IL-35 and TGF-β [55,56].